Latest Kamada News & Updates

See the latest news and media coverage for Kamada. We track all announcements, press releases, and industry mentions in real time, all in one place.

Kamada

Vertically integrated specialty plasma-derived biopharmaceutical company

kamada.com

Headquarters: Rehovot, Israel
Founded year: 1990
Company type: Public company
Number of employees: 360–500
Industry: Pharmaceuticals

Last updated September 17

Latest news about Kamada

In short: Kamada reported record H1 2026 results, launched biosimilars, and secured a $50M plasma supply deal.

Company announcements

August 17 Kamada

Kamada declares $0.17 cash dividend following record first-half results

The board approved the payout reflecting strong financial performance and solid cash position to support ongoing growth strategies.

August 12 Kamada

Kamada announces planned transition of CFO Chaime Orlev

Orlev, CFO since 2017, will depart December 31, 2026, with a successor search underway.

August 12 Kamada

Kamada reports record-high first half and Q2 2026 results

Revenues reached $100.2M in H1, up 13% year-over-year, and adjusted EBITDA was $25.7M, up 14%. The company reaffirms 2026 annual guidance.

July 20 Kamada

Kamada announces a three-year $50 million plasma supply agreement

The agreement with a leading biopharmaceutical company is expected to generate revenue from Q4 2026.

Media coverage

September 17 MSN

Kamada says KedRAB supplies are adequate as rabies cases rise in US

Kamada (KMDA) traded higher on Thursday after the Israeli biotech said that it maintains an adequate supply of KedRAB, its human immune globulin targeting rabies...

August 13 MSN

Should value investors buy Kamada (KMDA) stock?

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But...

August 7 The Globe and Mail

Kamada Delivers Record First-Half 2026 Results and Secures $50 Million Plasma Supply Deal

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities...

July 20 Globes

Kamada jumps on $50m source plasma deal

The new three-year agreement for the supply of normal source plasma from Kamada's plasma collection centers in Texas will produce about $50 million in revenue...

Never miss news about Kamada

Track Kamada and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Kamada competitors & trending companies

Browse news for competitors to Kamada and other trending companies.